Stay updated on Psilocybin vs Escitalopram for MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.

Latest updates to the Psilocybin vs Escitalopram for MDD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications notes in the Study Publications section were updated with revised wording and a new Revision: v3.3.2. The deletions replace older phrasing about PubMed-derived publications and automatically generated lists with updated wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoChange DetectedNotice about government funding lapse and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedNo additions or deletions detected; the Study Details page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

- Check69 days agoChange DetectedUpdate to v3.1.0 with removal of several drug-safety categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); retains reference to previous v3.0.2 revision.SummaryDifference0.4%

- Check83 days agoChange DetectedUpdated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No evident changes to the core page content.SummaryDifference0.2%

Stay in the know with updates to Psilocybin vs Escitalopram for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.